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MouseCyc database <p>MouseCyc is a database of curated metabolic pathways for the laboratory mouse.</p>
Abstract
Linking biochemical genetic data to the reference genome for the laboratory mouse is important
for comparative physiology and for developing mouse models of human biology and disease. We
describe here a new database of curated metabolic pathways for the laboratory mouse called
MouseCyc http://mousecyc.jax.org. MouseCyc has been integrated with genetic and genomic data
for the laboratory mouse available from the Mouse Genome Informatics database and with pathway
data from other organisms, including human.
Rationale
The availability of the nearly complete genome sequence for
the laboratory mouse provides a powerful platform for pre-
dicting genes and other genome features and for exploring the
biological significance of genome organization [1]. However,
building a catalog of genome annotations is just the first step
in the 'post-genome' biology [2,3]. Deriving new insights into
complex biological processes using complete genomes and
related genome-scale data will require understanding how
individual biological units that comprise the genome (for
example, genes and other genome features) relate to one
another in pathways and networks [4]. Identifying compo-
nents within networks can be achieved through genome-wide
assays of an organism's proteome or transcriptome using
high-throughput technologies such as microarrays; however,
it is the association of experimental data with well-curated
biological knowledge that provides meaningful context to the
vast amount of information produced in such experiments.
Ultimately, researchers seek to understand how perturba-
tions of these networks, presumably through study of dysreg-
ulated components, contribute to disease processes.
Biochemical interactions and transformations among organic
molecules are arguably the foundation and core distinguish-
ing feature of all organic life. Most of these transformations
are understood as sequential interactions among molecules.
Thus, biochemical pathways, rather than individual reactions
and molecules, are often the most useful 'units' of investiga-
tion for biomedical experimentalists by providing conceptual
reduction of biological system complexity. Biochemical path-
ways in mammalian systems historically have been character-
ized and defined with little or no genetic information, making
the present day task of connecting metabolism and genomics
a challenging enterprise.
The Kyoto Encyclopedia of Genes and Genomes (KEGG) was
one of the first projects that addressed the integration of
small molecule biochemical reaction networks with genes,
and it includes graphical representations of these reactions
[5,6]. KEGG pathways are based primarily on Enzyme Com-
mission (EC) classifications of enzymes [7]. For individual
species, the known (and predicted) EC enzymes are depicted
relative to KEGG reference networks for visualization of the
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sequential small molecule transformations that exist for a
given organism.
Another resource that seeks to integrate pathway and
genomic data is Reactome [8,9]. Reactome is a manually
curated database of human pathways, networks and proc-
esses, including metabolism, signaling pathways, cell-cell
interactions, and infection response. Data in Reactome are
cross-referenced to numerous external widely used genome
informatics resources. The curated human pathway data in
Reactome are used to infer orthologous pathways in over 20
other organisms that have complete, or nearly complete,
genome sequences and comprehensive protein annotations.
The non-human pathway data in Reactome are not manually
curated in a systematic fashion.
Another popular platform for integration of genetic and bio-
chemical knowledge is Pathway Tools, a software environ-
ment for curation, analysis, and visualization of integrated
genomic and pathway data [4,10]. The PathoLogic compo-
nent of Pathway Tools predicts complete and partial meta-
bolic pathways for an organism by comparing user-supplied
genome annotations (for example, gene names, EC numbers)
to a reference database (MetaCyc) of manually curated,
experimentally defined metabolic pathways [11,12]. The out-
put of PathoLogic analysis is an organism-specific pathway
genome database (PGDB) [13] that contains predicted enzy-
matic reactions, compounds, enzymes, transporters, and
pathways. Pathway Tools has been used to implement
curated PGDBs for a number of model eukaryotic organisms,
for example, budding yeast, Saccharomyces cerevisiae (Sac-
charomyces  Genome Database [14]), green alga,
Chlamydomonas reinhardtii (ChlamyCyc [15]), thale cress,
Arabidopsis thaliana (AraCyc [16]), rice, Oryza sativa (Rice-
Cyc [17]), plants of the Solanaceae family (SolCyc [18]),
human, Homo sapiens (HumanCyc [19]) and, very recently,
the bovine, Bos taurus (CattleCyc [20]), as well as for hun-
dreds of microorganisms [21]. All databases implemented
using Pathway Tools share a common web-based user inter-
face while also providing support for users of the software to
display organism-specific details and information for genes
and pathways.
Here, we describe the implementation and curation of the
MouseCyc database [22] using the Pathway Tools platform.
MouseCyc now joins the existing biochemical pathway
resources for major biomedically relevant model organisms,
providing ease of use through implementation of the Pathway
Tools web interface, and integration with other Mouse
Genome Informatics (MGI) resources [23]. MouseCyc con-
tains information on central, intermediary, and small-mole-
cule metabolism in the laboratory mouse and serves as a
resource for analyzing the mouse genome using the func-
tional framework of biochemical pathways. MouseCyc facili-
tates the use of the laboratory mouse as a model system for
understanding human biology and disease processes in three
ways. First, the database provides a means by which the avail-
able wealth of biological knowledge about mouse genes can be
organized in the context of biochemical pathways. Second,
the query and analysis tools for the database serve as a means
for researchers to view and analyze genome scale experiments
by overlaying these data onto global views of the curated
mouse metabolome. Finally, MouseCyc supports direct com-
parisons of metabolic processes and pathways between
mouse and human; comparisons that may be critical to
understanding both the power and the biological limitations
of using mouse models of human disease.
Implementation
Initial PathoLogic analysis, manual curation, and 
PathoLogic incremental updates
The initial implementation of the MouseCyc pathway genome
database using the PathoLogic prediction software with Path-
way Tools resulted in the prediction of 304 pathways, 1,832
enzymatic reactions, and 5 transport reactions. Following the
automated build of MouseCyc, the predicted reactions and
pathways were evaluated and refined manually. The initial
manual curation effort focused on identifying pathways and
reactions, predicted by PathoLogic, that were not relevant to
mammalian biochemistry (for example, biosynthesis of
essential amino acids). The manual curation process resulted
in the elimination of 135 non-mammalian pathways (45% of
the pathways predicted for mouse by PathoLogic) from the
database. The high percentage of predicted pathways in
MouseCyc that required manual re-assignment was not sur-
prising given that, for historic reasons, the MetaCyc reference
database [11,12] used by PathoLogic is somewhat biased
toward prokaryotic and plant biochemistry. Finally, Patho-
Logic's Transport Inference Parser (TIP) utility was used to
identify putative transport reactions. For the mouse genome,
TIP predicted 80 transport reactions and 542 transporters.
One of the obstacles that complicates unambiguously linking
enzymes to genes is that protein products of orthologous
genes do not necessarily have common biochemical functions
[24]. Moreover, studies of the same gene by different groups
do not necessarily report similar results as well. For example,
arginine decarboxylase (EC 4.1.1.19), which converts arginine
to agmatine in the 'arginine degradation III' pathway (Figure
1), was originally characterized biochemically in rats [25,26].
Agmatine is an important neurotransmitter that regulates a
number of biological functions in mammalian brain [27,28].
A human arginine decarboxylase gene (ADC) has been
reported to encode the enzyme in the first step of this pathway
[29]. The mouse ortholog (Adc) of the human enzyme, how-
ever, lacks amine decarboxylating activity and, instead,
appears to function as an ornithine decarboxylase antizyme
inhibitor (oazin) in the superpathway of ornithine degrada-
tion [30]. A more recent study indicates that human ADC pro-
tein also acts as an oazin [31]; however, contrary to previous
studies [29], the authors report that human ADC lackshttp://genomebiology.com/2009/10/8/R84 Genome Biology 2009,     Volume 10, Issue 8, Article R84       Evsikov et al. R84.3
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arginine decarboxylase activity like its mouse ortholog.
Finally, the protein product of the orthologous rat gene
RGD1564776 has not been biochemically characterized yet.
The example of arginine degradation illustrates two impor-
tant points relative to the MouseCyc project. First, the orthol-
ogy of enzymes does not always translate to functional
equivalency. Second, ongoing investigation into the details of
biochemistry necessitates regular manual curation and
refinement for effective and error-proof 'translation' of
advances in biochemistry to genomics.
Because of the limited amount of data on vertebrate organ-
isms within the reference database that PathoLogic relies on
for its predictions of metabolic potential (that is, the MetaCyc
database), a number of important pathways were missing
from the initial build of MouseCyc. Examples of curated bio-
chemical pathways for the mouse that have been also submit-
ted for inclusion in the MetaCyc reference database include
biosynthesis of androgens, biosynthesis of corticosteroids,
biosynthesis of estrogens, biosynthesis of prostaglandins,
biosynthesis of serotonin and melatonin, ceramide biosyn-
thesis, cyclic AMP biosynthesis, cyclic GMP biosynthesis, Lel-
oir pathway, sphingomyelin metabolism, sphingosine and
sphingosine-1-phosphate metabolism, and L-ascorbate bio-
synthesis VI (Additional data file 1). Thus, one of the major
ongoing manual curation processes for MouseCyc is the crea-
tion of records for biochemical pathways that are specific to
mammalian systems or the laboratory mouse that were not
predicted by PathoLogic.
The manual review of PathoLogic-predicted pathways for
MouseCyc revealed numerous individual enzymatic reactions
that cannot currently be associated with mouse-specific path-
ways. These reactions were not removed from MouseCyc;
instead, they have been retained for possible incorporation
into MouseCyc pathways at a later date. The rationale for
retaining 'orphan' enzymatic reactions in the database is two-
fold. First, there are a number of reactions that have been
identified enzymatically in mammalian systems (for example,
in rat liver extracts) for which no corresponding mammalian
gene has yet been reported. Second, the majority of the 'extra-
neous' pathways contained one or more reactions for which a
mouse enzyme has been either identified or predicted. They
could be structural units of not yet curated pathways. One of
the primary ongoing curation tasks for MouseCyc involves
discerning valid enzymes for reactions within pathways from
those erroneously assigned by PathoLogic. The main sources
of errors in PathoLogic predictions are the protein sequence
similarity-based inference of gene/protein function used in
genome annotations. This curation process includes a review
of published biochemical literature and protein sequence-
based analysis of gene families. A notable example is the alco-
hol dehydrogenase gene family (EC 1.1.1.1), in which an
'ancestral' enzyme, Adh3 (Adh5 in current nomenclature), is
a 'true' liver ethanol dehydrogenase, while the neofunctional-
ization of other family members during vertebrate evolution
resulted in the changes to substrate specificity, expression
pattern and enzymatic properties [32]. In this example, man-
ual curation of the 'Oxidative ethanol degradation I' pathway
predicted by PathoLogic resulted in the reduction of associ-
ated genes and encoded enzymes (Figure 2a versus 2b). Sim-
ilarly, the genes in the family of 3-hydroxy-5-steroid
dehydrogenases, while assigned to the 'same' reaction (EC
1.1.1.145), have unique expression patterns, act in different
branches of C21-steroid metabolic pathway and have differ-
ences in substrate specificity [33].
Comparison of mouse and human biochemical 
pathway databases
One of the primary benefits of using Pathway Tools for build-
ing PGDBs is that the software supports comparative metab-
olomics by allowing users to display the same pathway from
different PGDBs simultaneously. In addition to side-by-side
evaluation of individual pathways (Figure 2c), MouseCyc also
provides access to global overviews of similarities and differ-
ences among several selected PGDBs for other organisms
[34]. There are a number of biochemical pathways that differ
among mammalian species, usually due to the absence of a
critical functional enzyme in a pathway. For example, vitamin
C biosynthesis (L-ascorbate biosynthesis VI pathway) is dis-
rupted in humans and great apes as a result of ancestral non-
sense mutations in the gulonolactone oxidase (GULO) gene
[35]. Melatonin biosynthesis pathway is disrupted in a
number of inbred mouse strains due to the lack of cetylserot-
onin O-methyltransferase (Asmt) gene [36]. Purine degrada-
tion pathways in mouse and human differ in their final
metabolite that is secreted with urine. In humans, absence of
urate oxidase gene makes ureic acid the 'end product' of this
Mouse arginine degradation III (arginine decarboxylase/agmatinase) pathway Figure 1
Mouse arginine degradation III (arginine decarboxylase/agmatinase) pathway. The enzyme has been biochemically identified in rats [26], but the identities of 
the mammalian arginine decarboxylase genes remain elusive.
arginine 
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Oxidative ethanol degradation pathway in the mouse Figure 2
Oxidative ethanol degradation pathway in the mouse. (a) Initial PathoLogic prediction assigned six enzymes to EC 1.1.1.1, five enzymes for EC 1.2.1.3 and 
one enzyme for EC 6.2.1.13 reactions. (b) Manually resolved pathway for Mus musculus. The association of Adh6b with EC 1.1.1.1 was removed because, 
while no functional studies of ADH6B enzyme have been reported yet, the protein lacks Phe140, a strictly conserved residue in ethanol-active enzymes 
[32]. For EC 1.2.1.3, the list of genes was updated with only those aldehyde dehydrogenase superfamily members that have experimental evidence of 
involvement in ethanol metabolism. Finally, the last reaction in this pathway is EC 6.2.1.1, rather than EC 6.2.1.13, which is implicated in lipid biosynthesis. 
This posted correction to the MetaCyc database was propagated to the MouseCyc pathway using the PathoLogic incremental update tool. (c) The 
MouseCyc server permits direct comparison of a mouse biochemical pathway with the same pathway from an external PGDB, HumanCyc [19].
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pathway, while in mice, activity of Uox (EC 1.7.3.3) and Urah
(EC 3.5.2.17) leads to formation of allantoin, a much more
soluble and less toxic compound [37].
Integration of MouseCyc with Mouse Genome 
Informatics
One of the main goals for the MouseCyc database initiative
was to integrate the pathway-centered view of the mouse
genome with the extensive biological knowledge about mouse
genes and human disease phenotypes represented in the MGI
databases [23]. The integration of MouseCyc and MGI has
been achieved in two primary ways. First, the curated 'gene-
to-pathway' associations from MouseCyc are accessible from
the gene detail pages in the MGI database (Figure 3a). Cur-
rently, 1,058 genes are associated with 290 pathways and 5
super-pathways, that is, connected aggregations of smaller
pathways (release 1.44, July 2009). In addition to providing
pathway contexts for mouse genes (Figure 3b), MouseCyc
also contains information on the association of genes and
gene products with both mouse phenotypes and human dis-
eases. For example, human mutations in the galactose-1-
phosphate uridyl transferase gene (GALT) are associated with
classic galactosemia [38], a severe inborn error of metabolism
disease. Mice lacking a functional Galt gene exhibit high lev-
els of galactose-1-phosphate and galactose but are otherwise
phenotypically normal [39]. In MouseCyc, the associations of
genes and gene products with human disease information in
the On-Line Mendelian Inheritance in Man (OMIM) resource
[40] and mouse phenotype information in MGI are provided
on the protein summary pages (Figure 3c).
MouseCyc and the OmicsViewer
The MouseCyc OmicsViewer [41] is the second method uti-
lized for integration of gene- and protein-centric experimen-
tal data and annotations with the representation of metabolic
pathways. The OmicsViewer is a built-in utility for all path-
way genome databases implemented with PathwayTools. The
viewer was originally developed for visualizing genome-wide
gene expression data in the context of metabolic pathways.
However, the input format for the viewer is not specific to
expression data and can be adapted easily to provide a metab-
olome-centric overview of a wide variety of annotations, such
as metabolite measurements, or reaction-flux data estimated
using flux-balance analysis techniques. The input format for
the OmicsViewer is a tab-delimited file that contains gene,
protein or metabolite identifiers in the first column followed
by one or more data columns. Once the pathway overview
graphic is rendered, users can 'mouse-click' on pathways or
specific reactions within pathways to view details. Figure 4
shows all known mouse genes with targeted mutations and/
or gene trapped alleles (available at [42]) mapped onto mouse
biochemical pathways.
Testing MouseCyc as a hypothesis generation tool
In addition to serving as a mouse-specific reference database
of biochemical pathways, MouseCyc can also be used for gen-
Linking the MGI and MouseCyc databases Figure 3
Linking the MGI and MouseCyc databases. (a) Details of the MGI entry for 
the galactose-1-phosphate uridyl transferase (Galt) gene now include the 
list of biochemical pathways (shown in bold) associated with this gene. (b) 
Graphical representation of the Leloir pathway and the position of the 
GALT enzyme within it. (c) MouseCyc entry for the GALT enzyme, 
showing the description of the disease associated with the human ortholog 
of the mouse GALT enzyme.
Mus musculus  Enzyme: galactose-1-phosphate uridyl transferase   
Summary:  
In humans, mutations in the gene encoding galactose-1-phosphate uridyl transferase (GALT) cause classic galactosemia. The mouse model homozygous for the 
functional null allele of Galt gene cannot convert [14C]-galactose-1-phosphate to [14C]UDP galactose, which results in high levels of galactose-1-phosphate ( and 
galactose as well). However, despite the inability of these mice to metabolize galactose via a classical Leloir pathway, they l ack severe pathologies associated with 
galactosemia in humans, and are phenotypically normal [ Leslie96 ].  
Gene: Galt  
Sequence Length: 379 AAs  
Unification Links: UniProt:Q03249  
Gene-Reaction Schematic:   
 
GO Terms:  
Molecular Function:  GO:0008108 - UDP-glucose:hexose-1-phosphate uridylyltransferase activity 
GO:0008270 - zinc ion binding  
GO:0016740 - transferase activity  
GO:0016779 - nucleotidyltransferase activity  
GO:0046872 - metal ion binding  
MultiFun Terms:  UNCLASSIFIED 
 
Enzymatic reaction of: galactose-1-phosphate uridyl transferase  
 
 
The reaction direction shown, that is, A + B <==> C + D versus C + D <==> A + B, is in accordance with the Enzyme Commission system.  
Reversibility of this reaction is unspecified.  
In Pathways: Leloir pathway , colanic acid building blocks biosynthesis , UDP-galactose biosynthesis (salvage pathway from galactose using UDP-glucose)   
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An OmicsViewer representation of the metabolic pathways in MouseCyc Figure 4
An OmicsViewer representation of the metabolic pathways in MouseCyc. Reactions catalyzed by enzymes with targeted (knockout) mutation or gene trap 
alleles in the corresponding genes are shown in color: red depicts existence of both knockout and gene trap alleles; blue indicates knockout alleles; green 
indicates gene trap alleles. The graphic was generated by processing the Phenotypic Allele report from the MGI FTP site. The data of interest were 
converted to a two column tab-delimited file with current MGI symbols for genes in the first column and a numeric value in the second column. The 
numeric value indicated if a gene had a targeted allele, gene trapped allele, or both. Each value corresponded to a specific color among the range of colors 
supported by the OmicsViewer. The data used to generate this figure are available at [42].http://genomebiology.com/2009/10/8/R84 Genome Biology 2009,     Volume 10, Issue 8, Article R84       Evsikov et al. R84.7
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erating hypotheses about biological processes using genomic
data. To test the value of the OmicsViewer for hypothesis gen-
eration, we utilized the previously published data set of genes
expressed in the mouse oocytes [43] to explore the biochemi-
cal pathways operating in these cells. The most prominent
pathways identified in the mouse oocyte transcriptome are
'Protein citrullination' (Figure 5a) and 'Glycolysis III' (Figure
5b). Citrullination of proteins was recently found to be impor-
tant for the early stages of development [44]. Also, It is well
known that the oocytes and early cleavage embryos (which
rely on the maternal source of mRNAs and proteins for devel-
opment) cannot use glucose as an energy source [45]. Our
OmicsViewer analysis indicates that the oocytes (and, by
extrapolation, early embryos) lack any of the hexokinases,
which are enzymes involved in the first step of glycolysis -
phosphorylation of glucose to glucose-6-phosphate. From
this observation using MouseCyc and the OmicsViewer tool
we hypothesize that the absence of hexokinases is the under-
lying cause of 'glucose intolerance' by oocytes in mammals.
Discussion
Documenting the similarities and differences of biochemistry
and metabolism between mice and humans is particularly
important for investigators seeking to use the laboratory
mouse in animal studies related to drug therapies, toxicology,
and human disease. In our curation of MouseCyc to date we
have documented, and formally represented, differences in
metabolic potential among mammals that are due to the
absence of critical enzymes or to functional divergence of
putative orthologs. Connecting mouse genes and pathways to
human diseases in MouseCyc highlights differences in bio-
chemistry that cannot yet be clearly associated with specific
genes and proteins. For example, the Leloir pathway (Figure
3b) is the major route for galactose utilization in both mice
and humans. However, humans have galactosemias, while
mice do not, presumably due to yet unknown pathways of
galactose breakdown in the mouse. As proteomic and metab-
olomic research uncovers new biochemical pathways in the
mouse, they will be incorporated into MouseCyc to further
enhance the utility of this resource in facilitating the use of
the laboratory mouse as a model organism for understanding
human biology and disease.
A primary value-added aspect of the MouseCyc project rela-
tive to other pathway databases lies in the extent to which
pathways in MouseCyc have been integrated with the com-
prehensive functional and phenotypic knowledge of mouse
genes and the associations of mouse genes with human dis-
ease phenotypes that are available through the MGI
resources. In addition to the reciprocal hypertext links
between genes and pathways that are available in MGI and
MouseCyc, researchers can rapidly visualize the literature-
curated functional and phenotypic annotations of genes and
gene products available from MGI in the context of all bio-
chemical pathways known for mouse. As illustrated by the
Examples of prominent biochemical pathways identified in mouse oocytes Figure 5
Examples of prominent biochemical pathways identified in mouse oocytes. 
(a) The protein citrullination pathway has recently been shown to be 
essential for early development, as targeted mutation of Padi6 renders 
females infertile [44]. Note that Padi6 is the only gene of the peptidyl 
arginine deiminase family expressed in oocytes. (b) The inability of glucose 
utilization by mouse oocytes may be due to the lack of hexokinases 
required for the first step in glycolysis. Genes next to the corresponding 
reactions are shown in black (expressed in the oocytes) or in grey (not 
expressed).
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mouse oocyte transcriptome study described in this manu-
script (Figure 5), supporting the ability of researchers to nav-
igate easily among global views of the mouse metabolome,
specific pathways, and the details of individual genes and pro-
teins allows a systems-based approach for the analysis and
interpretation of genetic and genomic data.
The initial implementation of the MouseCyc database
required substantial manual refinement to make the presen-
tation of pathway knowledge more representative of mamma-
lian biology. The degree of manual refinement required was
due, in part, to the fact that most vigorous biochemical genet-
ics research has been performed using microorganisms such
as bacteria and yeast. As a result, the MetaCyc reference data-
base that was used for pathway prediction is somewhat biased
toward biology of unicellular microorganisms. The ongoing
incorporation of curated data from MouseCyc into MetaCyc,
as well as expansion of curatorial efforts for other projects
using mammalian systems, specifically HumanCyc [19] and
CattleCyc [20], will ensure that future applications of the
PathwayTools system to metazoan data sets will result in
improvement in the predictions of pathways that take into
account knowledge about animal, and specifically mamma-
lian, biology.
An important future direction for the MouseCyc resource will
be to represent explicitly the cell and tissue-type specificity of
particular pathways and their reactions. In the current imple-
mentation of the database, all genes encoding enzymes with
the same function are assigned to the same biochemical reac-
tion, making it impossible to discern the network of enzymes
executing a particular pathway in one tissue versus another.
For example, ethanol metabolism (Figure 2) depends on dif-
ferent enzymes in different tissues due to the differences in
gene expression for alcohol dehydrogenases, aldehyde dehy-
drogenases, and short-chain acyl-CoA synthesases. While
Pathway Tools was originally developed as software designed
for PGDBs of unicellular organisms (for which tissue specifi-
city is irrelevant), implementation of new biochemical data-
bases for higher organisms using this platform, such as
MouseCyc, will promote future developments of Pathway
Tools to address the subject of representation and visualiza-
tion for biochemical pathways that are processed by multiple,
differentially expressed genes encoding functionally similar
enzymes in different tissues.
Methodology
Installing pathway tools
The Pathway Tools development kit software (version 10.0)
was downloaded from Stanford Research Institute and
installed on each of two Sun Fire X4100 servers (2.6 Ghz/1
MB processor; 1 Gb memory; 73 Gb hard drive) running
SUSE Linux. One of the servers is devoted to development
and curation activities; the second server is the dedicated host
for the public instance of the MouseCyc database [22] and
HumanCyc [19].
The Pathway Tools software system has four main compo-
nents [10]. The PathoLogic component creates a PGDB for an
organism based on user-supplied organism-specific genome
annotations. The Pathway Tools Ontology defines the schema
of the database. The Pathway/Genome Navigator component
supports query, visualization and Web-publishing services
for PGDBs. Finally, the software includes Pathway/Genome
Editing tools permitting curators to edit and update data in
the baseline PGDB.
Mouse genome annotation
A catalog of mouse genes and annotations was downloaded
from the MGI FTP site (6 November 2007). The gene annota-
tions included gene name and symbol, EC numbers, Gene
Ontology annotations, genome coordinates (for NCBI build
36) and accession identifiers for EntrezGene, UniProt, and
MGI. RNA genes and pseudogenes were not included in the
annotation file.
A total of 47 files were created as input to the PathoLogic algo-
rithm following the format specifications outlined in the
Pathway Tools installation guide. Annotation files were cre-
ated for 19 mouse autosomes, 2 sex chromosomes, the mito-
chondrial genome, and for genes with unknown chromosome
location. For each annotation file, a separate chromosome
sequence file was created in FASTA format. Finally, a file (the
genetic elements file) to guide the instantiation of the chro-
mosomes and their annotations was also created.
Manual annotation
Following the automated build of MouseCyc, the data-editing
tools built into the Pathway Tools software system were used
for manual refinement and annotation of pathways and reac-
tions.
Display of mouse gene phenotype annotations using 
OmicsViewer
Pre-compiled OmicsViewer files for phenotype annotations of
mouse genes from the MGI database are available via FTP
[46]. These files can be uploaded directly into the Omics-
Viewer [41] to display phenotype annotations in the context
of the curated mouse metabolome.
Software and data updates
Updates to the Pathway Tools software are implemented as
they become available. MouseCyc currently runs on Pathway
Tools version 13.0.
The MouseCyc database is updated bi-monthly with new and
revised manually curated pathways. Updates to mouse
genome annotations (gene names, symbols, and so on) are
propagated to MouseCyc using the PathoLogic incremental
update utilities. With each genome annotation update, poten-http://genomebiology.com/2009/10/8/R84 Genome Biology 2009,     Volume 10, Issue 8, Article R84       Evsikov et al. R84.9
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tial new pathways and reactions are generated automatically
and reviewed manually. Information on the current content
and history of updates to MouseCyc can be found by following
the 'History of updates to this database' link on the MouseCyc
home page.
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